All four tumors were infiltrating ductal carcinomas and three of the tumors were estrogen receptor-negative, progesterone receptor-negative, and human epidermal growth factor receptor 2-negative (triple-negative). The gene discussed is ERBB2; the disease is invasive ductal breast carcinoma.